SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform for heart attack ...
The company's products, HeartBeam AIMI and HeartBeam AIMIGo, are being developed with the aim of providing accurate diagnostic tools for heart attack detection anytime and anywhere. The core ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D vector electrocardiogram (VECG) platform intended for ...
HeartBeam intends to initiate a limited launch of its ECG software device in Q1 2026. Image credit: YAKOBCHUK VIACHESLAV via Shutterstock.com. HeartBeam has secured US Food and Drug Administration ...
Branislav Vajdic, PhD, is the CEO and Founder of HeartBeam, Inc., a company developing a 3D-vector ECG platform for heart attack detection. The field of medicine sees a continual supply of new and ...
We are extremely pleased to have received this additional funding, which will allow us to achieve our important upcoming milestones and extends our cash runway into late 2024” — Branislav Vajdic, Ph.D ...
Greetings. And welcome to the HeartBeam Fourth Quarter and Full-Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results